EN
HI
Summary
As of 3 Nov, 2026, Lincoln Pharmaceuticals stock price is ₹512.2. During the trading session, the stock has moved between an intraday low of ₹499.30 and an intraday high of ₹514.60. Over the last 52 weeks, Lincoln Pharmaceuticals has traded between ₹440.00 and ₹770.00.
The stock has recorded a trading volume of 27,003 shares,. Its Average Traded Price (ATP) is ₹506.87, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 1 @ ₹512.20.
Lincoln Pharmaceuticals has an upper circuit limit of ₹599.15 and a lower circuit limit of ₹399.45. The total value traded stands at ₹1.37 CR, and the delivery percentage for the day is 35.24%.
The stock is currently traded with a market lot size of 1. Lincoln Pharmaceuticals also offers a dividend yield of 0.36%.
Lincoln Pharmaceuticals Share Price Chart
Lincoln Pharmaceuticals Share Key Metrics
Volume
27003.00
Market Cap
1025.92 CR
LTQ@LTP
1@512.20
ATP
506.87
Var Margin
20.23 %
Circuit Range
399.45-599.15
Delivery %
35.24 %
Value
1.37 CR
ASM/GSM
No
Market Lot
1
Lincoln Pharmaceuticals Fundamentals
P/E Ratio
10.38
P/B Ratio
1.24
Div. Yield
0.36
Sector P/E
39.15
Sector P/B
3.23
Sec. Div. Yield
0.54
Lincoln Pharmaceuticals Resistance and Support
Pivot 505.53
Resistance
First Resistance
516.96
Second Resistance
534.63
Third Resistance
546.06
Support
First Support
487.86
Second Support
476.43
Third Support
458.76
Lincoln Pharmaceuticals Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Mon Nov 02 2026 | 499.3 | 512.2 | 2.59% | 514.6 | 499.3 |
| Fri Oct 30 2026 | 511 | 499.29 | -2.08% | 523.2 | 494.1 |
| Thu Oct 29 2026 | 561 | 509.89 | -8.64% | 567.95 | 505 |
Lincoln Pharmaceuticals Corporate Actions
| Date | Agenda |
|---|---|
| 2026-10-29 | Quarterly Results |
| 2026-08-13 | Quarterly Results |
| 2026-05-28 | Audited Results & Final Dividend |
| 2026-02-12 | Quarterly Results |
| 2025-11-13 | Quarterly Results |
| 2025-08-07 | Quarterly Results |
| 2025-05-22 | Audited Results & Final Dividend |
| 2025-02-13 | Quarterly Results |
| 2024-11-14 | Quarterly Results |
| 2024-08-08 | Quarterly Results |
Lincoln Pharmaceuticals News
Lincoln Pharmaceuticals Ltd - 531633 - Board Meeting Outcome for Board Meeting Outcome For Un-Audited Financial Results For The Quarter And Half Year Ended On September 30, 2026.
Lincoln Pharmaceuticals reported Q2 FY27 cons. revenue of ₹200.88 crore, up 17.75% YoY, and a net profit of ₹20.84 crore, up 4.15% YoY. The company is targeting ₹1,000 crore revenue over the next three years driven by strong performance in key therapeutic segments.
Oct 29 2026 12:20:56
Lincoln Pharmaceuticals Ltd - 531633 - Board Meeting Intimation for Considering And Approving The Standalone And Consolidated Unaudited Financial Results Of The Company For The Quarter And Half Year Ended 30.09.2026.
Lincoln Pharmaceuticals board to meet on 29 Oct 2026 for financial results. Any further updates will be shared once the meeting concludes.
Oct 22 2026 14:47:29
Lincoln Pharmaceuticals Management
| Name | Position |
|---|---|
| Trusha Shah | Company Secretary & Compliance Officer |
| Kishor M Shah | Chairman |
Lincoln Pharmaceuticals Similar Stocks
Kopran Ltd.
242.21
3.16 (1.32%)
Bajaj Healthcare Ltd.
306.80
0.50 (0.16%)
3B Blackbio Dx Ltd.
1310.10
14.40 (1.11%)
GPT Healthcare Ltd.
134.80
2.12 (1.60%)
Bafna Pharmaceuticals Ltd.
438.95
-8.95 (2.00%)
Sigachi Industries Ltd.
25.86
-0.50 (1.90%)
Laxmi Dental Ltd.
180.24
2.66 (1.50%)
Anuh Pharma Ltd.
84.56
-2.75 (3.15%)
Unihealth Hospitals Ltd.
549.40
-0.85 (0.15%)
Sudarshan Pharma Industries Ltd.
35.16
-1.26 (3.46%)
Lincoln Pharmaceuticals FAQs
The Buying Price of Lincoln Pharmaceuticals share is 512.2 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Lincoln Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Lincoln Pharmaceuticals, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Lincoln Pharmaceuticals shares is 10.38. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Lincoln Pharmaceuticals shares is 1.24. Useful to assess the stock's value relative to its book value.
To assess Lincoln Pharmaceuticals’s valuation compare Sector P/E, P/B which are 39.15 & 3.23 with sector averages, along with growth rates and financial metrics.
The Market Cap of Lincoln Pharmaceuticals is 1025.92 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Lincoln Pharmaceuticals share price is 770.00 & 440.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Lincoln Pharmaceuticals belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in LINCOLN
